Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

NCT03541200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms (VMS)

Interventions

DRUG: MT-8554

Sponsor

Tanabe Pharma America, Inc.